S

Stanford Health Care | Stanford Neuroscience Health Center (SNHC)

Research site

(Unclaimed)

Location

213 Quarry Road Room 2726A, Palo Alto, California, United States of America

Site insights

Top conditions

Top treatments

BHV-7000

Platinum

Voriconazole

Isavuconazonium sulfate

Posaconazole

JNJ-81201887

thiazide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 13 total trials

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy (RISE 2)

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.

Enrolling

Focal Epilepsy

Drug: BHV-7000

Drug: Placebo

A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Active, not recruiting

Geographic Atrophy

Drug: Triamcinolone

Other: Sham Procedure

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)

Active, not recruiting

X-Linked Retinitis Pigmentosa

Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose

Biological: Genetic: AAV5-hRKp.RPGR Low Dose

Trial sponsors

C

I

V

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms